A shadow market for unapproved slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.
Experimental Treatment Gaining Traction Online
The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are encouraged to message these profiles privately for source information, while also obtaining promotional offers.
Thriving Trade on Social Networks
Additionally, a robust trade exists on Telegram, where groups with numerous of participants share “before and after” photos, injection guides and claims of rapid British shipping. Vendors market the drug there before directing buyers to other platforms for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.
Healthcare Experts Voice Concerns
However, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting products of unknown origin.
Several experts said the demand for retatrutide could be linked to the increasing price of approved slimming products such as Mounjaro.
Regulatory Position and Enforcement
Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be promoted or distributed for human use under the British medical regulations.
Several content creators try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach pharmaceutical, advertising, and consumer laws, potentially leading to penalties, prosecution or prison.
Service Response and Content Elimination
Based on TikTok, the platform has removed problematic material and banned related hashtags and query recommendations. The organization stated it was committed to keeping the service secure and investing in enhancing enforcement strategies.
Online Trading Activities
Research also found groups with up to 9,000 members marketing the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays channels with thousands of members, populated with photos of slimming results, positive reviews and detailed guides for mixing or administering at home.
After moments of joining one group, a vendor posted WhatsApp details, where most transactions take place. The seller sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about body mass, health issues or past usage.
Product Information and Pricing
Inside these groups, posts display dark colored parcels with postal service stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled injectors usually sold at £160 for 20 milligrams. When questioned how much time a injector should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Service Moderation and Security Actions
A spokesperson for the messaging service stated it actively monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are injecting substances they can’t verify. Although the research behind this drug is sound, these online versions may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the surge in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to social media. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.
Her team has previously seen patients injured by personal administration from unverified sources. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject patients to possibly significant medical dangers”.
